OpenLB
Open Library of Bioscience
Advanced Search
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Dec, 2021;25 (6): 728-876.

The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis.

Takaya Abe, Hidenori Matsuo, Ryuzo Abe, Shinji Abe, Hiroaki Asada, Akira Ashida, Akiyasu Baba, Kei Eguchi, Yutaka Eguchi, Yoshihiro Endo, Yoshihiro Fujimori, Kengo Furuichi, Yutaka Furukawa, Mayumi Furuya, Tomoki Furuya, Norio Hanafusa, Wataru Hara, Mariko Harada-Shiba, Midori Hasegawa, Noriyuki Hattori, Motoshi Hattori, Sumi Hidaka, Toshihiko Hidaka, Chika Hirayama, Shigaku Ikeda, Hideaki Imamura, Kazuaki Inoue, Keita Ishizuka, Kiyonobu Ishizuka, Takafumi Ito, Hitomi Iwamoto, Syoko Izaki, Maki Kagitani, Shuzo Kaneko, Naoto Kaneko, Takuro Kanekura, Kiyoki Kitagawa, Makio Kusaoi, Youwei Lin, Takeshi Maeda, Hisashi Makino, Shigeki Makino, Kenichi Matsuda, Takao Matsugane, Yusuke Minematsu, Michio Mineshima, Kenichiro Miura, Katsuichi Miyamoto, Takeshi Moriguchi, Mayumi Murata, Makoto Naganuma, Hajime Nakae, Shinya Narukawa, Atsushi Nohara, Kyoichi Nomura, Hirofumi Ochi, Atsushi Ohkubo, Takayasu Ohtake, Kazuya Okada, Tomokazu Okado, Yoshiki Okuyama, Susumu Omokawa, Satoru Oji, Norihiko Sakai, Yuichiro Sakamoto, Shigeru Sasaki, Motoyoshi Sato, Mariko Seishima, Hidetoshi Shiga, Homare Shimohata, Noriko Sugawara, Kohei Sugimoto, Yasushi Suzuki, Masato Suzuki, Takashi Tajima, Yasuhiro Takikawa, Satoru Tanaka, Kenjiro Taniguchi, Satoko Tsuchida, Tatsuo Tsukamoto, Kenji Tsushima, Yasunori Ueda, Takashi Wada, Hiromichi Yamada, Hiroyuki Yamada, Toshihiko Yamaka, Ken'ichiro Yamamoto, Yoko Yokoyama, Norihito Yoshida, Toyokazu Yoshioka, Ken Yamaji
Author Information
  1. Takaya Abe: The Japanese Society for Apheresis Guidelines Preparation Committee.
  2. Hidenori Matsuo: The Japanese Society for Apheresis Guidelines Preparation Committee.
  3. Ryuzo Abe: The Japanese Society for Apheresis Guidelines Preparation Committee.
  4. Shinji Abe: The Japanese Society for Apheresis Guidelines Preparation Committee.
  5. Hiroaki Asada: The Japanese Society for Apheresis Guidelines Preparation Committee.
  6. Akira Ashida: The Japanese Society for Apheresis Guidelines Preparation Committee.
  7. Akiyasu Baba: The Japanese Society for Apheresis Guidelines Preparation Committee.
  8. Kei Eguchi: The Japanese Society for Apheresis Guidelines Working Group.
  9. Yutaka Eguchi: The Japanese Society for Apheresis Guidelines Preparation Committee.
  10. Yoshihiro Endo: The Japanese Society for Apheresis Guidelines Preparation Committee.
  11. Yoshihiro Fujimori: The Japanese Society for Apheresis Guidelines Preparation Committee.
  12. Kengo Furuichi: The Japanese Society for Apheresis Guidelines Preparation Committee.
  13. Yutaka Furukawa: The Japanese Society for Apheresis Guidelines Working Group.
  14. Mayumi Furuya: The Japanese Society for Apheresis Guidelines Preparation Committee.
  15. Tomoki Furuya: The Japanese Society for Apheresis Guidelines Preparation Committee.
  16. Norio Hanafusa: The Japanese Society for Apheresis Guidelines Preparation Committee.
  17. Wataru Hara: The Japanese Society for Apheresis Guidelines Preparation Committee.
  18. Mariko Harada-Shiba: The Japanese Society for Apheresis Guidelines Preparation Committee.
  19. Midori Hasegawa: The Japanese Society for Apheresis Guidelines Preparation Committee.
  20. Noriyuki Hattori: The Japanese Society for Apheresis Guidelines Preparation Committee.
  21. Motoshi Hattori: The Japanese Society for Apheresis Guidelines Preparation Committee.
  22. Sumi Hidaka: The Japanese Society for Apheresis Guidelines Preparation Committee.
  23. Toshihiko Hidaka: The Japanese Society for Apheresis Guidelines Preparation Committee.
  24. Chika Hirayama: The Japanese Society for Apheresis Guidelines Working Group.
  25. Shigaku Ikeda: The Japanese Society for Apheresis Guidelines Preparation Committee.
  26. Hideaki Imamura: The Japanese Society for Apheresis Guidelines Preparation Committee.
  27. Kazuaki Inoue: The Japanese Society for Apheresis Guidelines Preparation Committee.
  28. Keita Ishizuka: The Japanese Society for Apheresis Guidelines Preparation Committee.
  29. Kiyonobu Ishizuka: The Japanese Society for Apheresis Guidelines Preparation Committee.
  30. Takafumi Ito: The Japanese Society for Apheresis Guidelines Preparation Committee.
  31. Hitomi Iwamoto: The Japanese Society for Apheresis Guidelines Preparation Committee.
  32. Syoko Izaki: The Japanese Society for Apheresis Guidelines Preparation Committee.
  33. Maki Kagitani: The Japanese Society for Apheresis Guidelines Preparation Committee.
  34. Shuzo Kaneko: The Japanese Society for Apheresis Guidelines Preparation Committee.
  35. Naoto Kaneko: The Japanese Society for Apheresis Guidelines Preparation Committee.
  36. Takuro Kanekura: The Japanese Society for Apheresis Guidelines Preparation Committee.
  37. Kiyoki Kitagawa: The Japanese Society for Apheresis Guidelines Preparation Committee.
  38. Makio Kusaoi: The Japanese Society for Apheresis Guidelines Preparation Committee.
  39. Youwei Lin: The Japanese Society for Apheresis Guidelines Preparation Committee.
  40. Takeshi Maeda: The Japanese Society for Apheresis Guidelines Preparation Committee.
  41. Hisashi Makino: The Japanese Society for Apheresis Guidelines Preparation Committee.
  42. Shigeki Makino: The Japanese Society for Apheresis Guidelines Preparation Committee.
  43. Kenichi Matsuda: The Japanese Society for Apheresis Guidelines Working Group.
  44. Takao Matsugane: The Japanese Society for Apheresis Guidelines Preparation Committee.
  45. Yusuke Minematsu: The Japanese Society for Apheresis Guidelines Working Group.
  46. Michio Mineshima: The Japanese Society for Apheresis Guidelines Preparation Committee.
  47. Kenichiro Miura: The Japanese Society for Apheresis Guidelines Preparation Committee.
  48. Katsuichi Miyamoto: The Japanese Society for Apheresis Guidelines Preparation Committee.
  49. Takeshi Moriguchi: The Japanese Society for Apheresis Guidelines Preparation Committee.
  50. Mayumi Murata: The Japanese Society for Apheresis Guidelines Working Group.
  51. Makoto Naganuma: The Japanese Society for Apheresis Guidelines Preparation Committee.
  52. Hajime Nakae: The Japanese Society for Apheresis Guidelines Preparation Committee.
  53. Shinya Narukawa: The Japanese Society for Apheresis Guidelines Preparation Committee.
  54. Atsushi Nohara: The Japanese Society for Apheresis Guidelines Preparation Committee.
  55. Kyoichi Nomura: The Japanese Society for Apheresis Guidelines Preparation Committee.
  56. Hirofumi Ochi: The Japanese Society for Apheresis Guidelines Preparation Committee.
  57. Atsushi Ohkubo: The Japanese Society for Apheresis Guidelines Working Group.
  58. Takayasu Ohtake: The Japanese Society for Apheresis Guidelines Preparation Committee.
  59. Kazuya Okada: The Japanese Society for Apheresis Guidelines Preparation Committee.
  60. Tomokazu Okado: The Japanese Society for Apheresis Guidelines Preparation Committee.
  61. Yoshiki Okuyama: The Japanese Society for Apheresis Guidelines Preparation Committee.
  62. Susumu Omokawa: The Japanese Society for Apheresis Guidelines Preparation Committee.
  63. Satoru Oji: The Japanese Society for Apheresis Guidelines Preparation Committee.
  64. Norihiko Sakai: The Japanese Society for Apheresis Guidelines Preparation Committee.
  65. Yuichiro Sakamoto: The Japanese Society for Apheresis Guidelines Preparation Committee.
  66. Shigeru Sasaki: The Japanese Society for Apheresis Guidelines Preparation Committee.
  67. Motoyoshi Sato: The Japanese Society for Apheresis Guidelines Preparation Committee.
  68. Mariko Seishima: The Japanese Society for Apheresis Guidelines Preparation Committee.
  69. Hidetoshi Shiga: The Japanese Society for Apheresis Guidelines Preparation Committee.
  70. Homare Shimohata: The Japanese Society for Apheresis Guidelines Preparation Committee.
  71. Noriko Sugawara: The Japanese Society for Apheresis Guidelines Preparation Committee.
  72. Kohei Sugimoto: The Japanese Society for Apheresis Guidelines Preparation Committee.
  73. Yasushi Suzuki: The Japanese Society for Apheresis Guidelines Preparation Committee.
  74. Masato Suzuki: The Japanese Society for Apheresis Guidelines Preparation Committee.
  75. Takashi Tajima: The Japanese Society for Apheresis Guidelines Preparation Committee.
  76. Yasuhiro Takikawa: The Japanese Society for Apheresis Guidelines Preparation Committee.
  77. Satoru Tanaka: The Japanese Society for Apheresis Guidelines Preparation Committee.
  78. Kenjiro Taniguchi: The Japanese Society for Apheresis Guidelines Working Group.
  79. Satoko Tsuchida: The Japanese Society for Apheresis Guidelines Preparation Committee.
  80. Tatsuo Tsukamoto: The Japanese Society for Apheresis Guidelines Preparation Committee.
  81. Kenji Tsushima: The Japanese Society for Apheresis Guidelines Preparation Committee.
  82. Yasunori Ueda: The Japanese Society for Apheresis Guidelines Preparation Committee.
  83. Takashi Wada: The Japanese Society for Apheresis Guidelines Preparation Committee.
  84. Hiromichi Yamada: The Japanese Society for Apheresis Guidelines Preparation Committee.
  85. Hiroyuki Yamada: The Japanese Society for Apheresis Guidelines Preparation Committee.
  86. Toshihiko Yamaka: The Japanese Society for Apheresis Guidelines Working Group.
  87. Ken'ichiro Yamamoto: The Japanese Society for Apheresis Guidelines Working Group.
  88. Yoko Yokoyama: The Japanese Society for Apheresis Guidelines Preparation Committee.
  89. Norihito Yoshida: The Japanese Society for Apheresis Guidelines Preparation Committee.
  90. Toyokazu Yoshioka: The Japanese Society for Apheresis Guidelines Preparation Committee.
  91. Ken Yamaji: The Japanese Society for Apheresis Guidelines Preparation Committee.
PMID: 34877777 DOI: 10.1111/1744-9987.13749

Abstract

Most of the diseases for which apheresis therapy is indicated are intractable and rare, and each patient has a different background and treatment course prior to apheresis therapy initiation. Therefore, it is difficult to conduct large-scale randomized controlled trials to secure high-quality evidence. Under such circumstances, the American Society for Apheresis (ASFA) issued its guidelines in 2007, which were repeatedly revised until the latest edition in 2019. The ASFA guidelines are comprehensive. However, in the United States, a centrifugal separation method is mainly used for apheresis, whereas the mainstream procedure in Japan is the membrane separation method. The target diseases and their backgrounds are different from those in Japan. Due to these differences, the direct adoption of the ASFA guidelines in Japanese practice creates various problems. One of the features of apheresis in Japan is the development of treatment methods using hollow-fiber devices such as double filtration plasmapheresis (DFPP) and selective plasma exchange and adsorption-type devices such as polymyxin B-immobilized endotoxin adsorption columns. Specialists in emergency medicine, hematology, collagen diseases/rheumatology, respiratory medicine, cardiovascular medicine, gastroenterology, neurology, nephrology, and dermatology who are familiar with apheresis therapy gathered for this guideline, which covers 86 diseases. In addition, since apheresis therapy involves not only physicians but also clinical engineers, nurses, dieticians, and many other medical professionals, this guideline was prepared in the form of a worksheet so that it can be easily understood at the bedside. Moreover, to the clinical purposes, this guideline is designed to summarize apheresis therapy in Japan and to disseminate and further develop Japanese apheresis technology to the world. As diagnostic and therapeutic techniques are constantly advancing, the guidelines need to be revised every few years. In order to ensure the high quality of apheresis therapy in Japan, both the Japanese Society for Apheresis Registry and the guidelines will be inseparable.

Keywords

apheresis clinical practice guideline

References

  1. Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34:171-354.

Grants

  1. /Japanese Society for Apheresis

MeSH Term

Blood Component Removal
Humans
Japan
Societies, Medical
Journal Article Practice Guideline
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0apheresistherapyguidelinesJapanguidelineJapaneseclinicaldiseasesSocietyApheresisASFApracticemedicinedifferenttreatmentrevisedseparationmethoddevicestherapeuticindicatedintractablerarepatientbackgroundcoursepriorinitiationThereforedifficultconductlarge-scalerandomizedcontrolledtrialssecurehigh-qualityevidencecircumstancesAmericanissued2007repeatedlylatestedition2019comprehensiveHoweverUnited StatescentrifugalmainlyusedwhereasmainstreamproceduremembranetargetbackgroundsDuedifferencesdirectadoptioncreatesvariousproblemsOnefeaturesdevelopmentmethodsusinghollow-fiberdoublefiltrationplasmapheresisDFPPselectiveplasmaexchangeadsorption-typepolymyxinB-immobilizedendotoxinadsorptioncolumnsSpecialistsemergencyhematologycollagendiseases/rheumatologyrespiratorycardiovasculargastroenterologyneurologynephrologydermatologyfamiliargatheredcovers86additionsinceinvolvesphysiciansalsoengineersnursesdieticiansmanymedicalprofessionalspreparedformworksheetcaneasilyunderstoodbedsideMoreoverpurposesdesignedsummarizedisseminatedeveloptechnologyworlddiagnostictechniquesconstantlyadvancingneedeveryyearsorderensurehighqualityRegistrywillinseparable

Similar Articles

Cited By